FIGURE 2-3. Timeline of advances in cancer care, highlighting improvements in the 5-year survival rate in the same time frame.

FIGURE 2-3Timeline of advances in cancer care, highlighting improvements in the 5-year survival rate in the same time frame

NOTE: BRCAI = breast cancer susceptibility gene 1; FDA = Food and Drug Administration; IL-2 = interleukin-2; IMRT = intensity modulated radiation therapy; mRNA = messenger ribonucleic acid.

SOURCE: Data derived from DeVita and Chu, 2008; DeVita and Rosenberg, 2012.

From: 2, Imperative: Managing Rapidly Increasing Complexity

Cover of Best Care at Lower Cost
Best Care at Lower Cost: The Path to Continuously Learning Health Care in America.
Committee on the Learning Health Care System in America; Institute of Medicine; Smith M, Saunders R, Stuckhardt L, et al., editors.
Washington (DC): National Academies Press (US); 2013 May 10.
Copyright 2013 by the National Academy of Sciences. All rights reserved.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.